Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-24

FDA Approved: SILODOSIN — Supplemental Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for silodosin. The applicant is Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

SUPPL AP for SILODOSIN (SILODOSIN)